Article
Top news of the day from across the health care landscape.
Researchers have found a link between e-cigarette usage and a higher risk of chronic lung diseases such as asthma, bronchitis, emphysema, and chronic obstructive pulmonary disease, according to US News and World Report. The team tracked data on cigarette and e-cigarette use of more than 32,000 US adults, none of whom had lung disease at the start of the study. They found that current and former e-cigarette users were 30% more likely to develop chronic lung disease, whereas tobacco smokers had more than a 2.6-times increased risk.
Study results have shown that 65.4% of patients with Parkinson disease reported experiencing symptom recurrence, known as OFF periods, which cause a significant impact on quality of life and financial stability, according to The American Journal of Managed Care. These OFF periods are shown to occur in 40% of patients after 4 to 6 years of treatment and in 90% after 10 years. The study, which examined the financial burden of patients with Parkinson disease (PD), found that 56.8% of participants with PD reported that symptom recurrence played a major role in the decisions to stop working.
The benefits of offering antiretroviral therapy (ART) on the same day as home-based HIV testing stood up in a 2-year follow-up of the CASCADE trial in Lesotho, Africa, according to Contagion Live. The CASCADE trial is among several studies to examine the effects of rapid ART initiation. The follow-up study found that although involvement in care and viral suppression leveled off at 24 months, there was no significant disengagement among patients who had received ART on the same day.
FDA Approves Bimekizumab-Bkzx as Treatment for Hidradenitis Suppurativa